Register entry

Delpharm Milano Srl

Data as of · How to read this entry

Registered sites
1
Active NDC listings
3
Live patents
0
Countries
1
Base
Italy
Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Delpharm Milano SrlVia Salvatore Carnevale 1, Segrate, MI 20054, Italy (ITA)Analytical testing, Labelling, Finished drug manufacture, Packaging3003716872437999026
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: DRUG FOR FURTHER PROCESSING 3.

Dosage formNDCs
capsule3
RouteNDCs
Labeller name on the listingNDCs
delpharm milano srl3
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
-ORLISTATcapsule71973-420DRUG FOR FURTHER PROCESSING
-OSELTAMIVIR PHOSPHATEcapsule71973-400DRUG FOR FURTHER PROCESSING
-OSELTAMIVIR PHOSPHATEcapsule71973-402DRUG FOR FURTHER PROCESSING
Neighbours

Registered in the same town

2
Compare

Comparable companies in Italy

Enquiry

Common questions

Is Delpharm Milano Srl FDA approved?
Delpharm Milano Srl holds 1 FDA-registered establishment in Italy. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Delpharm Milano Srl's drugs manufactured?
The FDA register lists Segrate. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does Delpharm Milano Srl make?
3 products are listed under Delpharm Milano Srl in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.